ANALYSIS OF PAIRED BRAFV600E MUTANT GLIOMA PATIENT SAMPLES IDENTIFIES NOVEL RESISTANCE MECHANISMS TO TARGETED BRAF INHIBITION

被引：0
|
作者：
Levy, Jean Mulcahy [1 ,2 ]
Sanford, Bridget [1 ]
Morin, Andrew [1 ,2 ]
Green, Adam [1 ,2 ]
Flannery, Patrick [1 ,2 ]
Jones, Kenneth [1 ]
Banerjee, Anurhada [3 ]
Nazemi, Kellie [4 ]
Samuel, David [5 ]
Kilburn, Lindsay [6 ]
Solomon, David [3 ]
Nicolaides, Theodore [3 ]
机构：
[1] Univ Colorado Denver, Aurora, CO USA
[2] Morgan Adams Pediat Brain Tumor Res Program, Aurora, CO USA
[3] Univ San Francisco, San Francisco, CA 94117 USA
[4] Oregon Hlth & Sci Univ, Portland, OR USA
[5] Valley Childrens Healthcare, Madera, CA USA
[6] Childrens Natl Hlth Syst, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TBIO-21
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [1] ANALYSIS OF PAIRED BRAFV600E MUTANT GLIOMA PATIENT SAMPLES IDENTIFIES NOVEL RESISTANCE MECHANISMS TO TARGETED BRAF INHIBITION
    Levy, Jean Mulcahy
    Sanford, Bridget
    Morin, Andrew
    Green, Adam
    Flannery, Patrick
    Jones, Kenneth
    Banerjee, Anuradha
    Solomon, David A.
    Nicolaides, Theo
    NEURO-ONCOLOGY, 2017, 19 : 198 - 198
  • [2] Resistance to BRAF and MEK inhibitors in BRAFV600E mutant melanoma
    Patel, Hima
    Mishra, Rosalin
    Joan, Garrett
    CANCER RESEARCH, 2019, 79 (13)
  • [3] BRAF Fusion as a Novel Mechanism of Acquired Resistance to Vemurafenib in BRAFV600E Mutant Melanoma
    Kulkarni, Atul
    Al-Hraishawi, Husam
    Simhadri, Srilatha
    Hirshfield, Kim M.
    Chen, Suzie
    Pine, Sharon
    Jeyamohan, Chandrika
    Sokol, Levi
    Ali, Siraj
    Teo, Man Lung
    White, Eileen
    Rodriguez-Rodriguez, Lorna
    Mehnert, Janice M.
    Ganesan, Shridar
    CLINICAL CANCER RESEARCH, 2017, 23 (18) : 5631 - 5638
  • [4] HSP90 INHIBITION OVERCOMES RESISTANCE TO MOLECULAR TARGETED THERAPY IN BRAFV600E MUTANT HIGH-GRADE GLIOMA
    Tateishi, Kensuke
    Sasame, Jo
    Naoki, Ikegaya
    Natsumeda, Manabu
    Kawazu, Masahito
    Wakimoto, Hiroaki
    Cahill, Daniel
    Yamamoto, Tetsuya
    NEURO-ONCOLOGY, 2022, 24 : 209 - 209
  • [5] PNA as novel targeted cancer therapy for BRAFV600E mutant melanoma
    Rothman, Jeffrey H.
    Surriga, Oliver
    Vasudeva, Shyamprasad D.
    Ambrosini, Grazia
    Ouerfelli, Ouathek
    Schwartz, Gary K.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAFV600E Mutant Glioma
    Maxwell, Micah J.
    Arnold, Antje
    Sweeney, Heather
    Chen, Lijun
    Lih, Tung-Shing M.
    Schnaubelt, Michael
    Eberhart, Charles G.
    Rubens, Jeffrey A.
    Zhang, Hui
    Clark, David J.
    Raabe, Eric H.
    MOLECULAR & CELLULAR PROTEOMICS, 2021, 20
  • [7] Context specific effects of the BRAFV600E mutation on hematopoiesis identifies novel models of BRAF mutant hematopoietic disorders
    Kim, Eunhee
    Chung, Stephen S.
    Park, Jae H.
    Chung, Young Rock
    Lito, Piro
    Feldstein, Julie
    Hu, Wenhuo
    Beguilin, Wendy
    Monette, Sebastien
    Duy, Cihangir
    Rampal, Raajit
    Telis, Leon
    Patel, Minal
    Kim, Min Kyung
    Melnick, Ari M.
    Rosen, Neal
    Tallman, Martin S.
    Park, Christopher Y.
    Abdel-Wahab, Omar
    CANCER RESEARCH, 2014, 74 (19)
  • [8] COMBINED BRAFV600E AND MEK INHIBITION FOR BRAFV600E-MUTANT ASTROCYTOMAS
    Zhang, Jie
    Hariono, Sujatmi
    Yao, Tsun-Wen
    Sidhu, Angadpreet
    Hashizume, Rintaro
    James, C. David
    Weiss, William A.
    Nicolaides, Theodore P.
    NEURO-ONCOLOGY, 2013, 15 : 60 - 61
  • [9] TARGETED THERAPY FOR BRAFV600E MUTANT MALIGNANT ASTROCYTOMA
    Nicolaides, Theodore
    Hariono, Sujatmi
    Barkovich, Krister
    Hashizume, Rintaro
    Rowitch, David
    Weiss, William
    Sheer, Denise
    Baker, Suzanne
    Paugh, Barbara
    Waldman, Todd
    Li, Huifang
    Jones, Chris
    Forshew, Tim
    James, David
    NEURO-ONCOLOGY, 2011, 13 : 112 - 112
  • [10] Multiomics detect potential mechanisms of resistance to BRAF targeted therapy in patients with BRAFV600E mutated solid tumors
    Eriksen, Martina
    Nielsen, Annelaura Bach
    Mundt, Filip
    Duel, Josephine Kerzel
    Mann, Matthias
    Lassen, Ulrik
    Yde, Christina Westmose
    Qvortrup, Camilla
    Hojgaard, Martin
    Spanggaard, Iben
    Rohrberg, Kristoffer Staal
    CANCER RESEARCH, 2022, 82 (12)
12345